Clinical Trial Update: A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II double-blind study evaluating Nowarta110 for plantar warts; the trial assessed safety and efficacy and results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plantar Warts

Drugs mentioned

• Nowarta110

Snippet

Sponsor: Nowarta Biopharma Inc | Conditions: Plantar Warts | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-07-19